NO20005187L - Én-sats syntese av 2-oksazolidinonderivater - Google Patents

Én-sats syntese av 2-oksazolidinonderivater

Info

Publication number
NO20005187L
NO20005187L NO20005187A NO20005187A NO20005187L NO 20005187 L NO20005187 L NO 20005187L NO 20005187 A NO20005187 A NO 20005187A NO 20005187 A NO20005187 A NO 20005187A NO 20005187 L NO20005187 L NO 20005187L
Authority
NO
Norway
Prior art keywords
oxazolidinone derivatives
way synthesis
synthesis
way
oxazolidinone
Prior art date
Application number
NO20005187A
Other languages
English (en)
Other versions
NO20005187D0 (no
NO311691B1 (no
Inventor
Rajnikant Patel
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20005187L publication Critical patent/NO20005187L/no
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO20005187D0 publication Critical patent/NO20005187D0/no
Publication of NO311691B1 publication Critical patent/NO311691B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20005187A 1995-08-07 2000-10-16 Fremgangsmåte for rensing av 2-oksazolidinonderivater samt ikke-solvatert, rent 2-oksazolidinonderivat NO311691B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516145.1A GB9516145D0 (en) 1995-08-07 1995-08-07 Improved chemical synthesis
PCT/GB1996/001885 WO1997006162A1 (en) 1995-08-07 1996-08-02 One pot synthesis of 2-oxazolidinone derivatives

Publications (3)

Publication Number Publication Date
NO20005187L true NO20005187L (no) 1998-02-06
NO20005187D0 NO20005187D0 (no) 2000-10-16
NO311691B1 NO311691B1 (no) 2002-01-07

Family

ID=10778867

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19980522A NO311690B1 (no) 1995-08-07 1998-02-06 Fremgangsmåte for fremstilling av 2-oksazolidinonderivater og mellomprodukter
NO20005187A NO311691B1 (no) 1995-08-07 2000-10-16 Fremgangsmåte for rensing av 2-oksazolidinonderivater samt ikke-solvatert, rent 2-oksazolidinonderivat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19980522A NO311690B1 (no) 1995-08-07 1998-02-06 Fremgangsmåte for fremstilling av 2-oksazolidinonderivater og mellomprodukter

Country Status (34)

Country Link
US (2) US6084103A (no)
EP (2) EP1227095B1 (no)
JP (6) JP3729503B2 (no)
KR (1) KR100670704B1 (no)
CN (3) CN1092657C (no)
AR (2) AR006515A1 (no)
AT (2) ATE325121T1 (no)
AU (1) AU718413B2 (no)
BR (1) BR9609830A (no)
CA (2) CA2572508C (no)
CZ (2) CZ301603B6 (no)
DE (2) DE69624825T2 (no)
DK (2) DK0843672T3 (no)
ES (2) ES2261545T3 (no)
GB (1) GB9516145D0 (no)
HK (2) HK1009129A1 (no)
HU (1) HU229966B1 (no)
IL (4) IL123171A (no)
IN (2) IN185148B (no)
MX (1) MX9801044A (no)
MY (1) MY117571A (no)
NO (2) NO311690B1 (no)
NZ (1) NZ315040A (no)
PL (1) PL188805B1 (no)
PT (2) PT1227095E (no)
RO (2) RO119618B1 (no)
RU (1) RU2167875C2 (no)
SI (2) SI1227095T1 (no)
SK (1) SK285052B6 (no)
TR (1) TR199800182T1 (no)
TW (1) TW358811B (no)
UA (1) UA53625C2 (no)
WO (1) WO1997006162A1 (no)
ZA (1) ZA966711B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001004088A1 (fr) * 1999-07-09 2001-01-18 Chugai Seiyaku Kabushiki Kaisha Procede de preparation de derives d'amiline
ES2204302B2 (es) * 2002-08-07 2005-03-01 Laboratorios Vita, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
US20070173536A1 (en) * 2004-02-06 2007-07-26 Ciba Specialty Chemicals Holding Inc. Crystalline forms of zolmitriptan
US20060211751A1 (en) * 2004-11-19 2006-09-21 Reuven Izsak Zolmitriptan crystal forms
JP4935675B2 (ja) 2005-08-25 2012-05-23 宇部興産株式会社 光学活性（Ｓ又はＲ）−α−アミノ酸及び光学活性（Ｒ又はＳ）−α−アミノ酸エステルの製造方法
ATE510836T1 (de) 2006-01-19 2011-06-15 Matrix Lab Ltd Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin
WO2008007390A2 (en) * 2006-07-10 2008-01-17 Natco Pharma Limited An improved process for purification of zolmitriptan
WO2008018090A2 (en) * 2006-08-09 2008-02-14 Matrix Laboratories Ltd An improved process for the preparation of zolmitriptan
CZ2007158A3 (cs) * 2007-02-26 2008-10-22 Zentiva, A. S. Zpusob prípravy zolmitriptanu
CZ301538B6 (cs) * 2007-02-26 2010-04-07 Zentiva, A. S. Zpusob prípravy zolmitriptanu
EP2201003A1 (en) 2007-10-03 2010-06-30 Generics Ýuk¨Limited Process for the preparation of zolmitriptan, salts and solvates thereof
CN101230047B (zh) * 2008-02-04 2010-08-04 江苏中威药业有限公司 一种4-取代手性噁唑烷酮类化合物的制备方法
EP2387993B1 (en) * 2010-05-21 2012-11-07 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of zolmitriptan and process for preparing the same
CN101948443B (zh) * 2010-08-17 2012-08-22 河南师范大学 一种简单、高效合成4-取代噁唑烷酮衍生物的方法
WO2012135615A2 (en) 2011-03-30 2012-10-04 Brown University Enopeptins, uses thereof, and methods of synthesis thereto
EP2751098B1 (en) 2011-09-02 2017-11-29 Emcure Pharmaceuticals Limited An improved process for preparation of zolmitriptan
CN102964270B (zh) * 2012-11-21 2015-01-07 合肥星宇化学有限责任公司 一种亚硫酸钠还原重氮盐合成肼的方法
CN103275075B (zh) * 2013-06-24 2015-01-07 成都天台山制药有限公司 佐米曲普坦及其制备方法
WO2016037072A2 (en) * 2014-09-04 2016-03-10 Brown University Enopeptin analogas and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
IL98392A (en) * 1990-06-07 1996-01-19 Wellcome Found History of indole, their preparation and the pharmaceutical preparations containing them
GB9401436D0 (en) * 1994-01-26 1994-03-23 Wellcome Found Therapeutic heterocyclic compounds
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
WO1996017842A1 (en) * 1994-12-06 1996-06-13 Merck Sharp & Dohme Limited Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists

Also Published As

Publication number Publication date
CA2572508C (en) 2010-03-30
KR100670704B1 (ko) 2007-07-11
CZ35298A3 (cs) 1998-06-17
CA2572508A1 (en) 1997-02-20
SK15498A3 (en) 1998-06-03
IN189756B (no) 2003-04-19
CZ301603B6 (cs) 2010-04-28
JP4634286B2 (ja) 2011-02-16
ATE227723T1 (de) 2002-11-15
MY117571A (en) 2004-07-31
IL148030A (en) 2010-05-17
EP1227095A3 (en) 2003-11-19
CA2227039A1 (en) 1997-02-20
MX9801044A (es) 1998-05-31
CA2227039C (en) 2007-12-04
EP1227095A2 (en) 2002-07-31
EP0843672B1 (en) 2002-11-13
HUP9900188A2 (hu) 1999-05-28
JP2006225406A (ja) 2006-08-31
HUP9900188A3 (en) 1999-11-29
SK285052B6 (sk) 2006-05-04
KR19990036165A (ko) 1999-05-25
CN1317480A (zh) 2001-10-17
JP2006077025A (ja) 2006-03-23
DK1227095T3 (da) 2006-07-31
ZA966711B (en) 1997-02-18
NO311690B1 (no) 2002-01-07
TR199800182T1 (xx) 1998-05-21
CN1142904C (zh) 2004-03-24
EP1227095B1 (en) 2006-05-03
US6160123A (en) 2000-12-12
CN1092657C (zh) 2002-10-16
NZ315040A (en) 2000-01-28
AR006515A1 (es) 1999-09-08
DE69636107T2 (de) 2007-05-03
AU6663496A (en) 1997-03-05
DE69624825T2 (de) 2003-09-04
NO20005187D0 (no) 2000-10-16
ES2185790T3 (es) 2003-05-01
TW358811B (en) 1999-05-21
JP2002097178A (ja) 2002-04-02
CZ293050B6 (cs) 2004-01-14
JP3739678B2 (ja) 2006-01-25
CN1403455A (zh) 2003-03-19
BR9609830A (pt) 1999-03-09
ATE325121T1 (de) 2006-06-15
ES2261545T3 (es) 2006-11-16
RO119618B1 (ro) 2005-01-28
PT843672E (pt) 2003-03-31
AU718413B2 (en) 2000-04-13
SI0843672T1 (en) 2003-04-30
PL324881A1 (en) 1998-06-22
IL123171A (en) 2003-10-31
JP3729503B2 (ja) 2005-12-21
GB9516145D0 (en) 1995-10-04
RU2167875C2 (ru) 2001-05-27
JPH11513023A (ja) 1999-11-09
UA53625C2 (uk) 2003-02-17
IL123171A0 (en) 1998-09-24
HU229966B1 (hu) 2015-03-30
NO980522D0 (no) 1998-02-06
SI1227095T1 (sl) 2006-08-31
CN1244579C (zh) 2006-03-08
IL156733A (en) 2007-07-04
WO1997006162A1 (en) 1997-02-20
JP2002308858A (ja) 2002-10-23
HK1047094A1 (en) 2003-02-07
DE69636107D1 (de) 2006-06-08
DE69624825D1 (de) 2002-12-19
CN1201460A (zh) 1998-12-09
HK1047094B (zh) 2006-10-13
PT1227095E (pt) 2006-08-31
IN185148B (no) 2000-11-25
PL188805B1 (pl) 2005-04-29
HK1009129A1 (en) 1999-05-28
IL148030A0 (en) 2002-09-12
JP2002037786A (ja) 2002-02-06
NO311691B1 (no) 2002-01-07
NO980522L (no) 1998-02-06
US6084103A (en) 2000-07-04
RO121816B1 (ro) 2008-05-30
IL156733A0 (en) 2004-02-08
EP0843672A1 (en) 1998-05-27
DK0843672T3 (da) 2003-02-17
AR046236A2 (es) 2005-11-30

Similar Documents

Publication Publication Date Title
NO974701D0 (no) Syntese av tale-bölgeformer
NO20005187L (no) Én-sats syntese av 2-oksazolidinonderivater
NO20001950D0 (no) Syntese av SAPO-44
PT1093815E (pt) Formulacao oral de 2-metil-tieno-benzodiazepina
NO973938D0 (no) Farmasöytisk preparat av piperdinoalkanolforbindelser
DK0805790T3 (da) Forbedret syntese af cyclopropylacetylen
DE69620399T2 (de) Sprachsynthese
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
NO982624L (no) FremgangsmÕte for syntese av benzimidazolforbindelse
FI973591A0 (fi) Nya syntetiserade kryptofysiner
NO982237D0 (no) Ny fremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO990832D0 (no) Syntese av bisendolylmalimider
NO960414L (no) Anvendelse av fenylcykloheksylkarboksylsyreamider
NO975869D0 (no) Forbedret syntese av 2,4,6,8,10,12-heksabenzyl-2,4,6,8,10,12-heksaazatetracyklo£5,5,0,05,9,03,11|dodecan
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
NO980532D0 (no) Anvendelse av en katalysator
NO964685D0 (no) Isomering av equilin
EE03382B1 (et) Tsüstiini mõnede derivaatide farmakoloogiline kasutamine
NO974458D0 (no) Fremstilling av cis-4-O-beskyttede-2-cyklopentenolderivater
NO914028L (no) Syntese av 4-methylthiazol
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
KR970041939U (ko) 부품의 방진체결구조
KR960027660U (ko) 원소 주기율표 괘도
KR970011853U (ko) 새로운 형태의 메리야스
FI972957A (fi) Kolmannen poskihampaan puhkeamisen ennustaja

Legal Events

Date Code Title Description
MK1K Patent expired